Market Place
Sourcing Support
LYNPARZA Demonstrates Prolonged Survival in Early Breast Cancer
11 Dec 2024 //
BUSINESSWIRE
Employees` LinkedIn likes land AstraZeneca and GSK in hot water
06 Dec 2024 //
FIERCE PHARMA
IMFINZI® Granted Priority Review for Muscle-Invasive Bladder Cancer
06 Dec 2024 //
BUSINESSWIRE
AstraZeneca, Daiichi share data behind Dato-DXd do-over
06 Dec 2024 //
FIERCE BIOTECH
AstraZeneca chided after complainant targets senior staff
05 Dec 2024 //
FIERCE PHARMA
AstraZeneca names exec to take on role of detained China head
05 Dec 2024 //
REUTERS
FDA approves Imfinzi for limited-stage small cell lung cancer
05 Dec 2024 //
REUTERS
AstraZeneca`s Biologic Imfinzi Receives Suppl Approval in US
04 Dec 2024 //
FDA
AstraZeneca’s Enhertu Wins China Reimbursement Despite Probe
30 Nov 2024 //
BLOOMBERG
AstraZeneca asthma drug more effective during attack than steroids
30 Nov 2024 //
REUTERS
AstraZeneca’s Enhertu Wins China Reimbursement Despite Probe
28 Nov 2024 //
BLOOMBERG
AstraZeneca gets nod for sale, distribution of cancer drug Lynparza
27 Nov 2024 //
BUSINESS STD
AstraZeneca Pharma shares up on CDSCO nod for cancer drug Lynparza
27 Nov 2024 //
BUSINESS STD
AZ`s Truqap carves path in prostate cancer with phase 3 win
26 Nov 2024 //
PRESS RELEASE
AstraZeneca India to launch Breztri Aerosphere in Jan 2025
23 Nov 2024 //
INDPHARMAPOST
AstraZeneca cans ph. 2 OUD drug over antifungal interaction
23 Nov 2024 //
FIERCE BIOTECH
Global Coalition for Adaptive Research Evaluates AZD1390 in GBM Trial
22 Nov 2024 //
PR NEWSWIRE
AstraZeneca cans ph. 2 OUD drug over antifungal interaction
22 Nov 2024 //
FIERCE BIOTECH
FDA raises safety flags ahead of adcomm for AZ`s Andexxa
20 Nov 2024 //
FIERCE PHARMA
AstraZeneca Awards $3.5M for US Healthcare Access Projects
20 Nov 2024 //
BUSINESSWIRE
NICE says AZ, Daiichi failed to propose fair price on Enhertu
19 Nov 2024 //
FIERCE PHARMA
AstraZeneca Pharma to launch COPD drug in Jan 2025; stock up 3%
19 Nov 2024 //
BUSINESS STD
AstraZeneca Pharma gains on plan to launch COPD drug
19 Nov 2024 //
BUSINESS STD
Lunit Collaborates with AstraZeneca on AI Pathology Tools
18 Nov 2024 //
PR NEWSWIRE
AstraZeneca India, Academy of Paediatrics Raise RSV Awareness
14 Nov 2024 //
EXPRESSPHARMA
AstraZeneca Pharma India Q2FY25 net profit falls 27% to Rs 38 cr
14 Nov 2024 //
BUSINESS STANDARD
AZ tacks on $2B to its investment in US manufacturing, R&D
13 Nov 2024 //
FIERCE PHARMA
AstraZeneca says China head has lawyer, but company still in dark
13 Nov 2024 //
REUTERS
AstraZeneca lifts 2024 revenue and profit forecast after Q3 beat
12 Nov 2024 //
REUTERS
Merck, AstraZeneca Announce Phase 3 Win for Cancer Drug
12 Nov 2024 //
FIERCE BIOTECH
Koselugo Shows Improve in NF1 Plexiform Neurofibromas in Ph 3 Trial
12 Nov 2024 //
BUSINESSWIRE
AstraZeneca’s 9M and Q3 2024 results
12 Nov 2024 //
BUSINESSWIRE
Amgen, AZ`s Tezspire excels in phase 3 rhinosinusitis trial
09 Nov 2024 //
FIERCE PHARMA
Enhertu Wins 2024 Prix Galien USA Best Biotech Product
08 Nov 2024 //
BUSINESSWIRE
Monopar Therapeutic Report Q3 2024 Financial Results & Developments
08 Nov 2024 //
GLOBENEWSWIRE
AstraZeneca Opens New ADC Manufacturing Facility in Singapore
07 Nov 2024 //
BIOSPECTRUM
AstraZeneca Showcases Hematology Portfolio & Pipeline at ASH 2024
07 Nov 2024 //
BUSINESSWIRE
AstraZeneca`s China chief in custody, believes unrelated to insurance probe
07 Nov 2024 //
REUTERS
AstraZeneca stock tanks over fears of expanding China probe
06 Nov 2024 //
FIERCE PHARMA
AstraZeneca shares fall on report of potential China probe fallout
05 Nov 2024 //
REUTERS
AstraZeneca says experimental obesity pill safe in early-stage trial
05 Nov 2024 //
REUTERS
Cellectis Reports Q3 2024 Business Updates and Results
04 Nov 2024 //
GLOBENEWSWIRE
AstraZeneca still `playing to win` in obesity, execs say
04 Nov 2024 //
FIERCE BIOTECH
AstraZeneca backs campaign to improve lives of COPD patients
04 Nov 2024 //
FIERCE PHARMA
AstraZeneca`s Byetta Receives Approval in US
01 Nov 2024 //
FDA
AstraZeneca`s China president faces `ongoing investigation`
30 Oct 2024 //
FIERCE PHARMA
Datopotamab Deruxtecan-Based Trials Start in Advanced NSCLC
30 Oct 2024 //
BUSINESSWIRE
Fasenra approved in the EU for eosinophilic granulomatosis (EGPA)
29 Oct 2024 //
PRESS RELEASE
BeiGene, ex-AstraZeneca exec faces investigation in China: reports
25 Oct 2024 //
FIERCE PHARMA
AZ licenses discarded rare disease drug to Monopar Therapeutics
25 Oct 2024 //
FIERCE BIOTECH
DoP Rejects Review Applications on Metoprolol Pricing
24 Oct 2024 //
PHARMABIZ
Eccogene Receives $60M Milestone Payment from AstraZeneca
23 Oct 2024 //
GLOBENEWSWIRE
AstraZeneca`s new TV spot for COPD drug Breztri sets sail
22 Oct 2024 //
FIERCE PHARMA
Wainzua Recommended For EU Approval For Hereditary Amyloidosis
21 Oct 2024 //
PR NEWSWIRE
AstraZeneca Advances Infectious Disease Protection Science At IDWeek
18 Oct 2024 //
INDPHARMAPOST
breast cancer pill could enter $12 bln market if trials succeed
09 Oct 2024 //
REUTERS
AZ pads data package for Airsupra in patients with milder asthma
09 Oct 2024 //
FIERCE PHARMA
AstraZeneca Puts $2B On The Line for Preclinical Heart Disease Drug
08 Oct 2024 //
BIOSPACE
AstraZeneca`s vision for the future of respiratory care
07 Oct 2024 //
FIERCE PHARMA
Thermo Fisher`s Infant making RSV Drug Plant Breached FDA Rules
05 Oct 2024 //
REUTERS
